CalciMedica, Inc. (CALC) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-100.0%

$0.00

vs $1.40 price

Levered DCF

$0.00

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

-15.99

Distress zone

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-3.35×	-2.9×	-0.37×	-0.25×	-0.25×	-0.08×	-0.16×	-0.18×
P/B	-14,896.04×	2.76×	1.57×	-0.97×	0.14×	0.03×	0.21×	0.42×
P/S	0×	0×	0×	0×	0×	0×	0×	0×
EV / EBITDA	-3,521.14×	-2.34×	-0.21×	-1.7×	0.13×	1.13×	-3.31×	-2.52×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Current ratio	3.58×	5.34×	2.88×	0.36×	16.53×	14.18×	2.96×	2.32×
Debt / equity	-1.46×	0×	0×	-0.58×	0×	0×	4.62×	6.56×
Interest coverage	-16.26×	0×	-346.14×	-107.52×	-285.29×	-208.62×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	445.1%	-95.1%	-421.2%	84.7%	-55.1%	-29.0%	-130.4%	-236.1%
Return on invested capital	-209.1%	-150.2%	-466.8%	1155.8%	-55.3%	-31.5%	-132.0%	-237.7%
Return on assets	-217.5%	-69.2%	-282.0%	-233.6%	-51.8%	-27.0%	-91.1%	-159.3%
Free cash flow yield	-0.0%	-53.1%	-201.0%	-131.2%	-361.7%	-1198.4%	-527.4%	-592.8%
Earnings yield	-0.0%	-34.4%	-267.5%	-87.3%	-405.1%	-997.2%	-613.9%	-566.8%
Enterprise value	$98.9B	$31.9M	$7.3M	$13M	-$4.5M	-$30.7M	$121.5M	$71M
Net debt / EBITDA	0.06×	0.58×	0.16×	-0.53×	0.38×	1.23×	-3.14×	-2.34×
Cash conversion cycle (days)	-9,212	0	0	0	-385	-2,322	-5,585	-5,262